The Effects of Treatment Regimen on the Initial Management of Macular Neovascularization Subtypes in Age-Related Macular Degeneration
Ophthalmologica · 2023 · 246 (2) · 113-122
DOI: 10.1159/000529409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ophthalmologica, online erschienen am 31.01.2023. Verfasst von Kenny Kodaday und 10 weiteren Autor:innen. Beteiligte Einrichtung: Service d'Ophtalmologie, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France. Hauptthemen laut MEDLINE: Angiogenesis Inhibitors, Macular Degeneration, Wet Macular Degeneration. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Introduction
The aim of this study was to evaluate the effect of initial treatment regimen individualization (pro re nata or treat-and-extend [TAE]), according to macular neovascularization (MNV) subtype, on the functional and anatomical response in neovascular age-related macular degeneration (nAMD). The secondary objective was to compare the treatment burden between each MNV subtype.
Methods
Consecutive treatment-naïve nAMD patients were retrospectively included. MNV subtype was graded by 2 independent blinded investigators on multimodal imaging. Functional and anatomical outcomes were analysed according to treatment regimen and MNV subtypes.
Results
A total of 281 eyes from 243 patients were included in the study. According to the treatment regimen, there was no significant difference in best-corrected visual acuity gain within the first 2 years of treatment for type 1 (p = 0.106) and type 3 MNV (p = 0.704). Conversely, there was a significant difference in favour of TAE regimen for type 2 (p = 0.017) and type 4 MNV (p = 0.047). Type 1 MNV had a higher proportion of visits with subretinal fluid (p = 0.0007) but not with intraretinal fluid (p = 0.22). The mean interval between the last 2 injections was significantly shorter for type 1 MNV (p = 0.0045).
Conclusion
The individualization of the initial treatment protocol according to MNV subtype can improve the functional outcome and may decrease the treatment burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service d'Ophtalmologie, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France.
- UMR-CNRS 5510 Matéis, Université Lyon 1, Villeurbanne, France.
- Service d'Ophtalmologie, Centre Hospitalier de Valence, Valence, France.
- Centre Ophtalmologique LEO, Hopital Privé de l'Est Lyonnais, Saint-Priest, France.
- Pôle Vision, Clinique du Val d'Ouest, Ecully, France.
- Service d'Ophtalmologie, Hôpital Universitaire Edouard Herriot, Hospices Civils de Lyon, Lyon, France.
Zitieren
APA
Kodaday, K., Kodjikian, L., Gadiollet, E., Chirpaz, N., Loria, O., Feldman, A., De Bats, F., Burillon, C., Denis, P., Pradat, P., & Mathis, T. (2023). The Effects of Treatment Regimen on the Initial Management of Macular Neovascularization Subtypes in Age-Related Macular Degeneration. Ophthalmologica, 246(2), 113-122. https://doi.org/10.1159/000529409
Vancouver
Kodaday K, Kodjikian L, Gadiollet E, Chirpaz N, Loria O, Feldman A, et al. The Effects of Treatment Regimen on the Initial Management of Macular Neovascularization Subtypes in Age-Related Macular Degeneration. Ophthalmologica. 2023;246(2):113-122. doi:10.1159/000529409
BibTeX
@article{Kodaday2023,
author = {Kodaday, Kenny and Kodjikian, Laurent and Gadiollet, Etienne and Chirpaz, Nicolas and Loria, Olivier and Feldman, Audrey and De Bats, Flore and Burillon, Carole and Denis, Philippe and Pradat, Pierre and Mathis, Thibaud},
title = {The Effects of Treatment Regimen on the Initial Management of Macular Neovascularization Subtypes in Age-Related Macular Degeneration},
journal = {Ophthalmologica},
year = {2023},
volume = {246},
number = {2},
pages = {113--122},
doi = {10.1159/000529409}
}
EUVIMED